Horizon Therapeutics (BSP:H1ZN34) Land And Improvements : R$215 Mil (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Horizon Therapeutics Land And Improvements?

Horizon Therapeutics's land and improvements for the quarter that ended in Jun. 2023 was R$215 Mil.

Horizon Therapeutics's quarterly land and improvements declined from Dec. 2022 (R$232 Mil) to Mar. 2023 (R$231 Mil) and declined from Mar. 2023 (R$231 Mil) to Jun. 2023 (R$215 Mil).

Horizon Therapeutics's annual land and improvements increased from Dec. 2020 (R$196 Mil) to Dec. 2021 (R$229 Mil) and increased from Dec. 2021 (R$229 Mil) to Dec. 2022 (R$232 Mil).

Horizon Therapeutics Land And Improvements Historical Data

The historical data trend for Horizon Therapeutics's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Horizon Therapeutics Land And Improvements Chart

Horizon Therapeutics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Land And Improvements

Get a 7-Day Free Trial

195.89

228.84

232.49

Horizon Therapeutics Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Land And Improvements	Get a 7-Day Free Trial															222.15	231.49	232.49	230.86	215.24

Horizon Therapeutics Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Horizon Therapeutics (BSP:H1ZN34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Horizon Therapeutics PLC (BSP:H1ZN34) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

70 St. Stephen’s Green, Dublin, IRL, D02 E2X4

Website

https://www.horizontherapeutics.com

Horizon Therapeutics PLC is a biotechnology company. The company is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Some of its pipeline products include UPLIZNA; HZN-825; Dazodalibep; Daxdilimab; TEPEZZA and others.

Horizon Therapeutics (BSP:H1ZN34) Headlines

No Headlines